Lab
Laboratorio Clinico Del Sureste,inc
Laboratorio Clinico Del Sureste,inc was paid $965K by Medicaid between Jan 2018 and Dec 2024, across 46 billing codes. Its largest line is 87426, Infectious agent antigen detection, SARS-CoV-2 (COVID-19) — 13% of everything it billed.
33Billing provider infoLABORATORIO CLINICO DEL SURESTE,INC
MAUNABO, PR 00707
MAUNABO, PR 00707
33aNPI1992112080assigned 07/21/2014
33bProvider typeClinical Medical Laboratory
28Total paid$965K
24GClaims81,398
24DCodes billed46
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#132 of 777
Median peer was paid$278K
This provider vs. median3.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,204 | $51K | |
| 2019 | 6,457 | $53K | |
| 2020 | 8,727 | $100K | |
| 2021 | 12,755 | $175K | |
| 2022 | 13,735 | $211K | |
| 2023 | 17,305 | $194K | |
| 2024incomplete | 16,215 | $182K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 13% | 3,364 | 2,905 | $123K |
| 84443 | Thyroid stimulating hormone (TSH) | 12% | 7,380 | 6,579 | $117K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 10% | 4,159 | 3,607 | $101K |
| 80061 | Lipid panel | 9.8% | 7,448 | 6,635 | $94K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.4% | 7,463 | 6,619 | $52K |
| 80053 | Comprehensive metabolic panel | 4.7% | 4,476 | 3,902 | $45K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.1% | 3,072 | 1,339 | $39K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 3.8% | 1,366 | 1,113 | $37K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 3.7% | 705 | 631 | $36K |
| 80048 | Basic metabolic panel (calcium, ionized) | 3.2% | 4,061 | 3,713 | $31K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2.8% | 2,984 | 2,636 | $27K |
| 81000 | 2.8% | 8,637 | 7,590 | $27K |
34 more codes
| 82274 | 2.3% | 1,564 | $22K | |
| 86702 | 2.2% | 1,789 | $21K | |
| 86738 | 2.1% | 1,673 | $20K | |
| 85027 | 2.0% | 3,508 | $20K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.0% | 578 | $19K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.9% | 572 | $19K |
| 36415 | Collection of venous blood by venipuncture | 1.8% | 3,440 | $17K |
| 86701 | 1.5% | 1,844 | $15K | |
| 86328 | 1.5% | 771 | $15K | |
| 80076 | 1.4% | 1,788 | $13K | |
| 84439 | 1.0% | 1,200 | $10K | |
| 86803 | <1% | 716 | $9K | |
| 84153 | <1% | 532 | $9K | |
| 82043 | <1% | 1,571 | $8K | |
| 86592 | <1% | 991 | $4K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 42 | $2K |
| 82947 | <1% | 529 | $2K | |
| 82570 | <1% | 361 | $2K | |
| 86703 | <1% | 115 | $1K | |
| 82607 | <1% | 118 | $1K | |
| 87088 | <1% | 170 | $1K | |
| 85652 | <1% | 508 | $1K | |
| 85730 | <1% | 181 | $934.17 | |
| 84436 | <1% | 116 | $738.67 | |
| 87590 | <1% | 38 | $726.56 | |
| 87490 | <1% | 38 | $726.56 | |
| 85610 | <1% | 193 | $674.39 | |
| 84479 | <1% | 91 | $525.22 | |
| 81001 | <1% | 50 | $173.00 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 498 | $147.70 |
| 84550 | <1% | 27 | $120.90 | |
| 84460 | <1% | 13 | $57.24 | |
| 84450 | <1% | 13 | $55.81 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 645 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCASTRO, YANIRE (GENERAL SUPERVISOR)
Parent organizationLABORATORIO CLINICO DEL SURESTE,INC
| Provider | Location | Paid |
|---|---|---|
| Laboratorio Clinico Del Sureste, INC | Yabucoa, PR | $2.14M |
| Laboratorio Clinico Del Sureste, INC | Yabucoa, PR | $1.83M |
| Laboratorio Clinicon Colon #3 | Humacao, PR | $436K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.